BlackRock Investment Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $164M | Sell |
6,002,547
-2,076,564
| -26% | -$56.7M | 0.19% | 106 |
|
2016
Q3 | $265M | Buy |
8,079,111
+872,075
| +12% | +$28.7M | 0.33% | 57 |
|
2016
Q2 | $218M | Buy |
7,207,036
+3,046,268
| +73% | +$92M | 0.28% | 77 |
|
2016
Q1 | $117M | Buy |
4,160,768
+438,044
| +12% | +$12.3M | 0.15% | 136 |
|
2015
Q4 | $126M | Sell |
3,722,724
-808,088
| -18% | -$27.4M | 0.16% | 126 |
|
2015
Q3 | $144M | Buy |
4,530,812
+190,296
| +4% | +$6.06M | 0.19% | 108 |
|
2015
Q2 | $138M | Buy |
4,340,516
+953,646
| +28% | +$30.4M | 0.17% | 122 |
|
2015
Q1 | $116M | Buy |
3,386,870
+76,560
| +2% | +$2.62M | 0.15% | 144 |
|
2014
Q4 | $116M | Buy |
3,310,310
+1,370,116
| +71% | +$48.2M | 0.15% | 145 |
|
2014
Q3 | $69.3M | Buy |
1,940,194
+891,540
| +85% | +$31.8M | 0.1% | 203 |
|
2014
Q2 | $39M | Sell |
1,048,654
-1,876,496
| -64% | -$69.7M | 0.05% | 332 |
|
2014
Q1 | $94.9M | Buy |
2,925,150
+202,734
| +7% | +$6.58M | 0.14% | 157 |
|
2013
Q4 | $80.8M | Buy |
2,722,416
+1,141,112
| +72% | +$33.9M | 0.12% | 180 |
|
2013
Q3 | $41.1M | Buy |
1,581,304
+287,580
| +22% | +$7.47M | 0.07% | 266 |
|
2013
Q2 | $30.6M | Buy |
+1,293,724
| New | +$30.6M | 0.05% | 319 |
|